Taking low-dose aspirin may reduce the risk of severe illness or death from COVID-19, study says

Taking low-dose aspirin may reduce ICU admissions and in-hospital deaths of COVID-19 patients, according to a new study. 

Researchers at George Washington University published their findings, which indicate the lung-protective effects of the affordable, over-the-counter pills, in the journal Anesthesia & Analgesia on Wednesday.  Doctors were particularly interested in studying aspirin's effects on coronavirus patients because it is one of the cheapest, most widely available drugs. Other drugs to treat COVID-19, such as remdesivir, can be prohibitively expensive.